Bausch & Lomb (BLCO) Capital Expenditures (2021 - 2026)
Bausch & Lomb's (BLCO) quarterly Capital Expenditures came in at $71.0 million in Q2 2026, down 20.22% on a YoY basis from $89.0 million in Q2 2025, and down 29.0% quarter-over-quarter from $100.0 million in Q1 2026.
Analysis
Bausch & Lomb (BLCO) Capital Expenditures (2021 - 2026) Analysis & Trends
Bausch & Lomb (BLCO) has reported Capital Expenditures for 6 consecutive years, with $71.0 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Capital Expenditures fell 20.22% year-over-year to $71.0 million; the trailing twelve-month figure through Jun 2026 stood at $321.0 million (down 8.55% YoY), and the FY2025 full-year result was $349.0 million, up 19.93% from the prior year.
- Capital Expenditures eased to $71.0 million in Q2 2026 per BLCO's latest filing, from $100.0 million in the prior quarter.
- Across five years, Capital Expenditures topped out at $110.0 million in Q1 2025 and bottomed at $27.0 million in Q2 2023.
- Historically, Capital Expenditures has averaged $64.8 million across 5 years, with a median of $69.0 million in 2024.
- The sharpest annual moves came in 2023 and 2024: Capital Expenditures sank 32.65% in 2023, then soared 166.67% in 2024.
- Over 5 years, Capital Expenditures stood at $50.0 million in 2022, then surged by 68.0% to $84.0 million in 2023, then increased by 9.52% to $92.0 million in 2024, then dropped by 17.39% to $76.0 million in 2025, then dropped by 6.58% to $71.0 million in 2026.
- According to Business Quant data, Capital Expenditures over the past three periods registered $71.0 million, $100.0 million, and $76.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 497.00 Mn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 112.60 Mn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 503.00 Mn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 202.00 Mn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 195.00 Mn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 66.90 Mn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | -96.00 Mn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 84.70 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 87.50 Mn |
| 10 | Bausch & Lomb | 6.28 Bn | 5.90 Bn | 867.00 Mn | 71.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 71.00 Mn |
| Mar 31, 2026 | 100.00 Mn |
| Dec 31, 2025 | 76.00 Mn |
| Sep 30, 2025 | 74.00 Mn |
| Jun 30, 2025 | 89.00 Mn |
| Mar 31, 2025 | 110.00 Mn |
| Dec 31, 2024 | 92.00 Mn |
| Sep 30, 2024 | 60.00 Mn |
| Jun 30, 2024 | 72.00 Mn |
| Mar 31, 2024 | 67.00 Mn |
| Dec 31, 2023 | 84.00 Mn |
| Sep 30, 2023 | 33.00 Mn |
| Jun 30, 2023 | 27.00 Mn |
| Mar 31, 2023 | 37.00 Mn |
| Dec 31, 2022 | 50.00 Mn |
| Sep 30, 2022 | 49.00 Mn |
| Jun 30, 2022 | 34.00 Mn |
| Mar 31, 2022 | 42.00 Mn |
| Dec 31, 2021 | 62.00 Mn |
| Sep 30, 2021 | 41.00 Mn |